Manufacturer record

Regain Laboratories 134/5: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Regain Laboratories 134/5 (Chhattisgarh) were declared Not of Standard Quality between September 2024 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to Regain Laboratories 134/5 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2024 to Aug 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
1
Products affected
Description
Most common failure
Aug 2025
Latest alert

Flagged batches per year

2024 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Gentamicin Injection IP (Gentatore Injection) IGMK445Mfg 2024-11 · Exp 2026-10 Particulate matter and DescriptionDescription CDL, KolkataCDSCO lab Aug 2025
Gentamicin Injection I.P. (Gentagain ) IGMJ330Mfg 2023-10 · Exp 2025-09 Description & Particulate matterDescription CDL KolkataCDSCO lab Sep 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.